
Glenmark Pharma Q4 net profit zooms to ₹301 crore; recommends 250% dividend
Glenmark’s Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended…

Glenmark’s Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended…

Revenue surges 62% YoY to ₹11,343 crore, while shares close over 4% lower ahead of earnings announcement

The company’s revenue increased 44% YoY, margin expanded to 15.5% while EBITDA rose 76%; the board recommended a final dividend of ₹0.60 per share. Shares…

The acquisition was completed under the tariff-based competitive bidding (TBCB) process through a bid process coordinator. Shares of Power Grid Corporation of India Ltd ended…

Lupin said it has received approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application for Sodium Sulfate,…

The scope of the order includes works at Pantnagar Airport in Uttarakhand on an EPC basis. Shares of PNC Infratech Ltd ended at ₹203, down…

S&P 500, Nasdaq and Dow hit fresh highs as US Iran talks and ceasefire hopes lift sentiment, oil prices ease, and Dell Technologies surges on…

TSMC nears $2 trillion valuation, driving Taiwan to fifth largest market and boosting growth, while Samsung and SK Hynix dominate Korea, raising concentration concerns.

The board also recommended a final dividend of ₹1.25 per equity share of face value ₹10 each for FY26, subject to shareholder approval at the…

IndiGo reported a ₹2,536 crore quarterly loss as foreign exchange losses, high fuel costs and weaker operating margins overshadowed modest growth in passengers and revenue.